In recent trading session, NLS Pharmaceutics Ltd (NASDAQ:NLSP) saw 0.92 million shares changing hands at last check today with its beta currently measuring 0.17. Company’s recent per share price level of $2.23 trading at -$0.02 or -0.89% at last check today assigns it a market valuation of $8.02M. That most recent trading price of NLSP’s stock is at a discount of -599.1% from its 52-week high price of $15.59 and is indicating a premium of 41.7% from its 52-week low price of $1.30. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.29 million shares which gives us an average trading volume of 281.74K if we extend that period to 3-months.
For NLS Pharmaceutics Ltd (NLSP), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
NLS Pharmaceutics Ltd (NASDAQ:NLSP) trade information
Upright in the red during last session for losing -0.89%, in the last five days NLSP remained trading in the red while hitting it’s week-highest on Thursday, 07/17/25 when the stock touched $2.23 price level, adding 5.11% to its value on the day. NLS Pharmaceutics Ltd’s shares saw a change of -72.80% in year-to-date performance and have moved -0.45% in past 5-day. NLS Pharmaceutics Ltd (NASDAQ:NLSP) showed a performance of -1.76% in past 30-days. Number of shares sold short was 72299.0 shares which calculate 0.15 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 33.06% during past 5 years.
NLS Pharmaceutics Ltd (NASDAQ:NLSP)’s Major holders
Insiders are in possession of 32.46% of company’s total shares while institution are holding 10.04 percent of that, with stock having share float percentage of 14.86%. Investors also watch the number of corporate investors in a company very closely, which is 10.04% institutions for NLS Pharmaceutics Ltd that are currently holding shares of the company. BVF INC/IL is the top institutional holder at NLSP for having 5.75 million shares of worth $1.25 million. And as of 2024-06-30, it was holding 15.0543 of the company’s outstanding shares.
The second largest institutional holder is ARMISTICE CAPITAL, LLC, which was holding about 2.31 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.0535 of outstanding shares, having a total worth of $0.5 million.
